REMBAVIOS
LIVE

Serial Number

99779427

Owner

Vertex Pharmaceuticals Incorporate

Attorney

Lisa M. Tittemore

Filing Date

Apr 22, 2026

Add to watchlist:

No watchlists yet
View on USPTO

REMBAVIOS Trademark

Serial Number: 99779427

REMBAVIOS is a trademark filed by Vertex Pharmaceuticals Incorporate on April 22, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Vertex Pharmaceuticals Incorporate (2 trademarks)

50 Northern Avenue
Boston, MA 02210

Entity Type: 03

Trademark Details

Filing Date

April 22, 2026

Registration Date

Not Registered

Published for Opposition

August 18, 2026

Goods & Services

pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of immunoglobulin A nephropathy; pharmaceutical preparations for the treatment of primary membranous nephropathy; pharmaceutical preparations for the treatment of lupus nephritis; pharmaceutical preparations for the treatment of renal antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis; pharmaceutical preparations for the treatment of immune thrombocytopenia; pharmaceutical preparations for the treatment of immune thrombocytopenia purpura; pharmaceutical preparations for the treatment of cold autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of warm autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the treatment of blood diseases and disorders; pharmaceutical preparations for the treatment of inflammation related diseases and disorders

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 18, 2026 NPUB
PUBLISHED FOR OPPOSITION
Aug 18, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 12, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 21, 2026 CNSA
ASSIGNED TO EXAMINER
Jul 21, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 22, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 22, 2026 NWOS
NEW APPLICATION ENTERED
Apr 22, 2026 NWAP